Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Clin Cancer Res. 2016 Jun 24;23(2):407–415. doi: 10.1158/1078-0432.CCR-16-0362

Figure 1.

Figure 1

Kaplan-Meier curves of progression-free survival (PFS) for prespecified quantitative imaging classifiers predicting endocrine response (N=84, p>0.05 for all). A. FES dynSUV = average of FES SUVmean of up to 3 lesions in the dynamic field-of-view B. FES SUL3 = geometric mean of FES SULmean (lean-body-mass adjusted FES SUVmean) for up to 3 lesions in torso sweep with highest FDG SUVmax C. any low FES/FDG = presence of any lesion with FES SULmean < 1 and FDG SUVmax > 5 D. qualitative FES neg = presence of any lesion lacking FES uptake above background (qualitative read).